Biotech Firm Pops 677% on Social Anxiety Spray Trial Success
A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., notched its best day ever, surging by as many as four digits after its experimental nasal spray for social anxiety disorder hit...